| Primary |
| Blood Cholesterol Increased |
33.3% |
| Renal Failure |
33.3% |
| Urinary Tract Infection |
33.3% |
|
| Medication Error |
20.0% |
| Pharmaceutical Product Complaint |
20.0% |
| Product Label Confusion |
20.0% |
| Unevaluable Event |
20.0% |
| Urinary Tract Infection |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
32.8% |
| Drug Use For Unknown Indication |
20.9% |
| Osteoporosis |
4.5% |
| Hypothyroidism |
4.4% |
| Coronary Artery Disease |
3.4% |
| Hypoparathyroidism |
3.4% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Hypocalcaemia |
2.7% |
| Asthma |
2.6% |
| Hypertension |
2.6% |
| Ill-defined Disorder |
2.6% |
| Hiv Infection |
2.4% |
| Mineral Supplementation |
2.2% |
| Pain |
2.2% |
| Prophylaxis |
2.1% |
| Acute Lymphocytic Leukaemia |
1.9% |
| Drug Exposure During Pregnancy |
1.8% |
| Osteopenia |
1.8% |
| Crohn's Disease |
1.3% |
| Depression |
1.3% |
|
| Completed Suicide |
13.0% |
| Tinnitus |
9.0% |
| Toxic Epidermal Necrolysis |
8.0% |
| Lenticular Opacities |
7.0% |
| Abortion Spontaneous |
5.0% |
| Haematochezia |
5.0% |
| Toothache |
5.0% |
| Weight Decreased |
5.0% |
| Drug Interaction |
4.0% |
| Interstitial Granulomatous Dermatitis |
4.0% |
| Rash |
4.0% |
| Renal Tubular Necrosis |
4.0% |
| Sepsis |
4.0% |
| Tendonitis |
4.0% |
| Toxicity To Various Agents |
4.0% |
| Creutzfeldt-jakob Disease |
3.0% |
| Dizziness |
3.0% |
| Haematemesis |
3.0% |
| Hypercalcaemia |
3.0% |
| Myalgia |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.6% |
| Drug Use For Unknown Indication |
17.5% |
| Rheumatoid Arthritis |
7.6% |
| Osteoporosis |
7.5% |
| Hypertension |
5.3% |
| Pain |
3.2% |
| Crohn's Disease |
2.9% |
| Supplementation Therapy |
2.3% |
| Prophylaxis |
2.3% |
| Vitamin Supplementation |
2.3% |
| Depression |
2.2% |
| Blood Cholesterol Increased |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Mineral Supplementation |
1.8% |
| Breast Cancer |
1.6% |
| Asthma |
1.4% |
| Diabetes Mellitus |
1.2% |
| Osteoporosis Postmenopausal |
1.2% |
| Hypothyroidism |
1.1% |
| Multiple Sclerosis |
1.1% |
|
| Vomiting |
11.6% |
| Weight Decreased |
10.1% |
| Weight Increased |
7.2% |
| Pain |
6.0% |
| Pain In Extremity |
6.0% |
| Nausea |
5.9% |
| Urinary Tract Infection |
4.9% |
| Drug Ineffective |
4.6% |
| Pruritus |
4.5% |
| Pneumonia |
4.4% |
| Rash |
4.2% |
| Death |
4.1% |
| Pyrexia |
4.0% |
| Injection Site Pain |
3.6% |
| Flushing |
3.5% |
| Headache |
3.4% |
| Vision Blurred |
3.1% |
| Tremor |
3.1% |
| Dyspnoea |
2.9% |
| Paraesthesia |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
67.7% |
| Product Used For Unknown Indication |
17.2% |
| Convulsion |
4.0% |
| Plasma Cell Myeloma |
2.0% |
| Blood Pressure Diastolic Abnormal |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Epilepsy |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Infective Exacerbation Of Bronchiectasis |
1.0% |
| Lower Respiratory Tract Infection |
1.0% |
| Osteoporosis |
1.0% |
| Pseudomonas Infection |
1.0% |
| Smoking Cessation Therapy |
1.0% |
|
| Drug Interaction |
29.4% |
| Prescribed Overdose |
17.6% |
| Treatment Failure |
17.6% |
| Cardio-respiratory Arrest |
5.9% |
| Feeling Abnormal |
5.9% |
| Malabsorption |
5.9% |
| Shoulder Operation |
5.9% |
| Speech Disorder |
5.9% |
| Vulvovaginal Dryness |
5.9% |
|
